Current use of glucocorticoids in patients with rheumatoid arthritis in Germany
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: To describe the current use of glucocorticoids in German patients with rheumatoid arthritis (RA). Methods: We analyzed clinical and patient‐derived data from 10,068 outpatients with RA from the national database of the German Collaborative Arthritis Centres for the year 2001 collected by more than 80 rheumatologists in hospitals and private practices. Results: Systemic glucocorticoid therapy was prescribed for 60% of all patients with RA in rheumatologic care. The proportion of patients receiving systemic glucocorticoids in addition to disease‐modifying antirheumatic drug (DMARD) therapy ranged from 53% to 81% of the patients for the various DMARDs. Glucocorticoid therapy was administered more often in combination with tumor necrosis factor inhibitors (81%), cyclosporin A (80%), or leflunomide (77%) than with more traditional DMARDs such as methotrexate (63%) or sulfasalazine (55%). Regarding the prevention and treatment of osteoporosis, 63% of patients taking systemic glucocorticoids were also receiving some type of osteoporosis therapy, as opposed to only 26% of those not taking glucocorticoids. Conclusion: Glucocorticoids play a pivotal role in the management of RA. This is reflected in the extensive use of low‐dose glucocorticoids by German rheumatologists. Even if highly effective DMARDs are prescribed, they are accompanied by glucocorticoids, at least in the initial phase. High‐dose glucocorticoids are prescribed for only a small proportion of the patients. There is increasing awareness of the risk of osteoporosis in long‐term glucocorticoid treatment, demonstrated by the fact that osteoporosis medication is prescribed for a large proportion of patients taking glucocorticoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Self-citationWalsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Molecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone · doi:10.1016/s8756-3282(01)00610-x · Cited by 201
Self-citation
Cited by
Genomic and nongenomic effects of glucocorticoids
Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0898 · Cited by 594
Dose-related patterns of glucocorticoid-induced side effects
Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., Zink, A., & Buttgereit, F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092163 · Cited by 604
Self-citationButtgereit, F., Doering, G., Schaeffler, A., Witte, S., Sierakowski, S., Gromnica-Ihle, E., Jeka, S., Krueger, K., Szechinski, J., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60132-4 · Cited by 405
Self-citationStrehl, C., Bijlsma, J. W. J., de Wit, M., Boers, M., Caeyers, N., Cutolo, M., Dasgupta, B., Dixon, W. G., Geenen, R., Huizinga, T. W. J., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208916 · Cited by 340
Self-citationDixon, W. G., Abrahamowicz, M., Beauchamp, M.-E., Ray, D. W., Bernatsky, S., Suissa, S., & Sylvestre, M.-P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200702 · Cited by 339
Metadata
- Authors
- Thiele, K., Buttgereit, F., Huscher, D., Zink, A., & Centres, T. G. C. A.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2005-10-05
- Volume
- 53
- Issue
- 5
- Pages
- 740-747
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2093022889
- Cited by
- 61
- References
- 3
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current use of glucocorticoids in patients with rheumatoid arthritis in Germany. https://app.cochat.ai/papers/10.1002/art.21467
- The paper
- Thiele, K., Buttgereit, F., Huscher, D., Zink, A., & Centres, T. G. C. A. (2005). Current use of glucocorticoids in patients with rheumatoid arthritis in Germany. Arthritis Care & Research. https://doi.org/10.1002/art.21467
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.